Clinicopathological Significance of S100A4 Expression in Non-small Cell Lung Carcinomas.
Eun Ah Jung, Hyun Deuk Cho, Ji Hye Lee, Mee Hye Oh
Korean J Pathol. 2010;44(5):477-482.     DOI: https://doi.org/10.4132/KoreanJPathol.2010.44.5.477
Citations to this article as recorded by Crossref logo
S100A4 promotes endometrial cancer progress through epithelial-mesenchymal transition regulation
TENG HUA, SHUANGGE LIU, XIAOYAN XIN, LIQIONG CAI, RUI SHI, SHUQI CHI, DILU FENG, HONGBO WANG
Oncology Reports.2016; 35(6): 3419.     CrossRef
Prognostic value of cytoplasmic expression of S100A4 protein in endometrial carcinoma
HYE IN CHONG, JEONG HEE LEE, MAN SOO YOON, DONG SOO SUH, KYUNGBIN KIM, JEE YEON KIM, KYUNG UN CHOI
Oncology Reports.2014; 31(6): 2701.     CrossRef
Clinical significance of E-cadherin, ╬▓-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma
Hua Zhang, Jun Liu, Dongsheng Yue, Liuwei Gao, Daowei Wang, Hongdian Zhang, Changli Wang
Journal of Clinical Pathology.2013; 66(11): 937.     CrossRef
Expression of S100A4, ephrin-A1 and osteopontin in non-small cell lung cancer
Ane Kongsgaard Rud, Marius Lund-Iversen, Gisle Berge, Odd Terje Brustugun, Steinar K Solberg, Gunhild M M├Žlandsmo, Kjetil Boye
BMC Cancer.2012;[Epub]     CrossRef
Clinicopathologic Implication of Ezrin Expression in Non-small Cell Lung Cancer
Ho Won Lee, Eui Han Kim, Mee-Hye Oh
Korean Journal of Pathology.2012; 46(5): 470.     CrossRef